SightfileU.S. market data from official filings

Companies › ELVN

ENLIVEN THERAPEUTICS INC (ELVN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001672619 · EDGAR filings · Updated 2026-07-21

ENLIVEN THERAPEUTICS INC (ELVN) has reported institutional ownership of 102.4%, with 171 institutional managers holding positions valued at $2.43B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
102.4%
Institutional managers
171
Reported 13F value
$2.43B
Insider activity
107 trans.
−$16.0M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENLIVEN THERAPEUTICS INC has 171 institutional holders and institutional ownership of 102.4%.

Insider activity

Insiders reported 107 transactions (0 buys, 88 sells) across 7 reporting insiders, with a net reported value of −$16.0M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2022-08-03 (recurring since 2020-05-07) — source filing. The authoritative details are those stated in the filing itself.

Related companies

NATIONAL VISION HLDGS INC COM (EYE) · DENTSPLY SIRONA INC (XRAY) · MINERALYS THERAPEUTICS INC (MLYS) · VIKING THERAPEUTICS INC (VKTX) · LEMAITRE VASCULAR INC (LMAT) · BIOCRYST PHARMACEUTICALS INC (BCRX)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.